期刊文献+

携SH2-Caspase8融合基因重组腺病毒的构建及对K562细胞增殖的影响 被引量:2

Construction of recombinant adenovirus carrying SH2-Caspase8 fusion gene and its effect on proliferation in K562 cells
下载PDF
导出
摘要 目的构建并鉴定携SH2-Caspase8融合基因的重组腺病毒AdE-SC-EGFP及其突变体,观察其对K562细胞增殖的抑制作用。方法采用RT-PCR、重叠PCR扩增SH2-Caspase8融合基因,克隆至腺病毒穿梭载体pAdTrack-CMV中,构建穿梭质粒pAdT-SC-EGFP,进行酶切和测序鉴定。将PmeⅠ酶切后的穿梭质粒转化pAdEasy-BJ5183感受态,通过细菌内同源重组产生复制缺陷型重组腺病毒质粒pAdE-SC-EGFP及其突变体,PacⅠ酶切后将其转染AD293细胞进行包装,PCR和Western blot鉴定重组腺病毒AdE-SC-EGFP,验证后扩增病毒并测定滴度。结果 PCR检测、酶切和测序结果均表明腺病毒穿梭质粒pAdT-SC-EGFP和重组腺病毒质粒pAdE-SC-EGFP构建成功;PCR检测、EGFP表达检测结果证明重组腺病毒AdE-SC-EGFP包装成功,扩增后,滴度可达1.5×1012pfu/ml。感染K562细胞后,Western blot检测目的蛋白的表达,MTT和半固体集落形成实验检测其对K562细胞生长增殖的影响。结论成功构建并鉴定了携带SH2-Caspase8融合基因的重组腺病毒AdE-SC-EGFP及其突变体;MTT和克隆形成实验证明重组腺病毒AdE-SC-EGFP对BCR-ABL阳性的K562细胞有明显的增殖抑制作用。 Objective To construct the recombinant adenovirus carrying SH2-Caspase8 fusion gene and its mutant to observe its inhibitory effect on proliferation of K562 cells.Methods SH2-Caspase8 fusion gene was amplified by RT-PCR and splicing PCR,and cloned into the shuttle plasmid pAdTrack-CMV of adenovirus.The shuttle plasmid pAdT-SC-EGFP was constructed and identified by double-enzyme digestion and DNA sequencing,and transformed into ultra-competent pAdEasy-BJ5183 after PmeⅠdigestion.Defective replication recombinant adenovirus plasmid pAdE-SC-EGFP and its mutant were generated by homologous recombination and further transfected into AD293 cells to package recombinant adenovirus after PacⅠdigestion.Recombinant adenovirus plasmid AdE-SC-EGFP was identified by PCR and Western blotting,respectively,and amplified for the measurement of its titers.Results PCR,enzyme digestion and DNA sequencing showed that the shuttle and recombinant plasmids of adenovirus,pAdT-SC-EGFP and pAdE-SC-EGFP,were successfully constructed.PCR and EGFP expression confirmed that the recombinant plasmid of adenovirus,pAdE-SC-EGFP,was successfully packaged.After amplification,its titer was 1.5×1012 pfu/ml.Western blot analysis displayed the expression of target protein.MTT and colony formation test could inhibit the proliferation of K562 cells.Conclusion Recombinant adenovirus plasmid,AdE-SC-EGFP,carrying SH2-Caspase8 fusion gene and its mutant,has been successfully constructed,and can significantly inhibit the proliferation of BCR-ABL positive K562 cells in vitro.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第18期1887-1892,共6页 Journal of Third Military Medical University
基金 国家自然科学基金(30871102)~~
关键词 细胞增殖 SH2 CASPASE8 重组腺病毒 构建 K562细胞 BCR-ABL cell proliferation SH2 Caspase8 recombinant adenovirus construction K562 cell bcr-abl
  • 相关文献

参考文献13

  • 1Druker B J. Translation of the Philadelphia chromosome into therapy for GML[J]. Blood, 2008, 112(13): 4808-4817.
  • 2Schiffer C A. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia[J]. N Engl J Med, 2007, 357(3) : 258 -265.
  • 3Luo J, Deng Z L, Luo X, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system [ J ]. Nat Protoc, 2007, 2(5) : 1236 -1247.
  • 4Brehme M, Hantschel O, Colinge J, et al. Charting the molecular network of the drug target Bcr-Abl[ J]. Proc Natl Acad Sci U S A, 2009, 106(18) : 7414 -7419.
  • 5Chu S, Li L, Singh H, et al. BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia[J]. Cancer Res, 2007, 67 (14) : 7045 -7053.
  • 6Pendergast A M, Quilliam L A, Cripe L D, et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein[J]. Cell, 1993, 75( 1 ) : 175 - 185.
  • 7Ulasov I V, Tyler M A, Han Y, et al. Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits ef- fective gene transfer to malignant glioma[J]. Hum Gene Ther, 2007, 18(2) : 118 -129.
  • 8Sweigard J H, Cashman S M, Kumar-Singh R. Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration [ J ]. Gene T- her, 2011, 18(6): 613-621.
  • 9Huang P T, Chen K C, Prijovich Z M, et al. Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of beta-glucuronidase in tumors[J]. Cancer Gene Ther, 2011, 18(6) : 381 -389.
  • 10罗红伟,田文君,季茂胜,刘钉宾,王小飞,黄宗干,冯文莉.β-TrCP-OD-HA重组腺病毒对白血病K562细胞凋亡的影响[J].第三军医大学学报,2010,32(15):1602-1604. 被引量:3

二级参考文献22

共引文献6

同被引文献11

  • 1齐静,彭晖,顾振纶,梁中琴,杨纯正.伊马替尼耐药的K562细胞系的建立及其生物学特性研究[J].中华血液学杂志,2004,25(6):337-341. 被引量:20
  • 2Krause,DS,Van,Etten,RA,黄艳.癌症治疗的靶点——酪氨酸激酶[J].中国处方药,2005(10):33-36. 被引量:45
  • 3Druker BJ. Translation of the Philadelphia chromosome into therapyfor CML[J]. Blood, 2008, 112(13) : 4808-4817.
  • 4Quintas-Cardama A, Kantarjian H,Cortes J. Flying under the radar :the new wave of BCR-ABL inhibitors [ J ]. Nat Rev Drug Discov,2007,6(10) : 834-848.
  • 5Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic myeloge-nous leukemia [ J ]. N Engl J Med, 2007,357(3 ) : 258-265.
  • 6Pendergast AM, Quilliam LA, Cripe LD, et al. BCR-ABL inducedoncogenesis is mediated by direct interaction with the SH2 domain ofthe GRB-2 adaptor protein[ J]. Cell, 1993 ,75( 1 ) : 175-185.
  • 7Puil L, Liu J, Gish G, et al. Bcr-Abl oncoproteins binddirectly toactivators of the Ras signalling pathway[ J]. EMBO J,1994,13(4):764-773.
  • 8Chu S, Li L, Singh H,et al. BCR-tyrosine 177 plays an essentialrole in Ras and Akt activation and in human hematopoietic progenitortransformation in chronic myelogenous leukemia [ J ]. Cancer Res,2007,67(14) :7045-7053.
  • 9KischkelFC, Lawrence DA, Chuntharapai A, et al. FADD/MORT1and caspase-8 are recruited to TRAIL receptors 1 and 2 and are es-sential for apoptosis mediated by TRAIL receptor 2 [ J] . Immunity,2000, 12(6) :599-609.
  • 10PengZ,Yuan Y,Li YJ, et al. Targeting BCR tyrosinel77 site withnovel SH2-DED causes selective leukemia cell death in vitro and invivo[J]. Int J Biochem Cell Biol, 2012,44(6) :861-868.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部